Because our data regarding Socs2 expression and growth regulatory effects of Socs2 derived from TP53 wt mice/cells and TP53 mutant human myeloid cells, we suggest that these effects are independent of p53 and TP53 mutations in AML. The gene discussed is TP53; the disease is acute myeloid leukemia.